Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 28972014

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2017 Dec 7
First author
Boidol B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Dec 7;130(23):2447-2448. doi: 10.1182/blood-2017-10-809673.
    note
    Source null
    related pmid
    29217697
    relationship
    Comment in

Authors and identifiers

  1. name
    Boidol B
    type
    Author
  2. name
    Kornauth C
    type
    Author
  3. name
    van der Kouwe E
    type
    Author
  4. name
    Prutsch N
    type
    Author
  5. name
    Kazianka L
    type
    Author
  6. name
    Gültekin S
    type
    Author
  7. name
    Hoermann G
    type
    Author
  8. name
    Mayerhoefer ME
    type
    Author
  9. name
    Hopfinger G
    type
    Author
  10. name
    Hauswirth A
    type
    Author
  11. name
    Panny M
    type
    Author
  12. name
    Aretin MB
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Boidol B
    type
    Author
  2. name
    Kornauth C
    type
    Author
  3. name
    van der Kouwe E
    type
    Author
  4. name
    Prutsch N
    type
    Author
  5. name
    Kazianka L
    type
    Author
  6. name
    Gültekin S
    type
    Author
  7. name
    Hoermann G
    type
    Author
  8. name
    Mayerhoefer ME
    type
    Author
  9. name
    Hopfinger G
    type
    Author
  10. name
    Hauswirth A
    type
    Author
  11. name
    Panny M
    type
    Author
  12. name
    Aretin MB
    type
    Author
bibliography ids
  1. nci-bib-eaa8a35778eb310ec83a446f
book metadata
content sha256
715a16072ec9882d70e90e321b5e2b20c1882f73bdb63ae505efc029f611c8c2
document type
citation
dois
  1. 10.1182/blood-2017-05-785683
electronic publication date
display
2017 Sep 27
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28972014
immutable id
pubmed:28972014@715a16072ec9882d70e90e321b5e2b20c1882f73bdb63ae505efc029f611c8c2
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
23
name
Blood
nlm unique id
7603509
pages
2499-2503
volume
130
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Dec 7;130(23):2447-2448. doi: 10.1182/blood-2017-10-809673.
    note
    Source null
    related pmid
    29217697
    relationship
    Comment in
outcomes validated
false
pmid
28972014
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
bb77b620d0e8eee98f7846aacdf0db420c32cf46272af86542be92b50378d01f
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Dec 7
precision
day
year
2017
publication types
  1. Case Reports
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28972014/
title
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.

Preserved source evidence · Independent clinical review pending · Not medical advice